Maraviroc

In the US, Maraviroc (maraviroc systemic) is a member of the drug class chemokine receptor antagonist and is used to treat HIV Infection.

US matches:

• Maraviroc

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AX09

CAS registry number (Chemical Abstracts Service)

0376348-65-1

Chemical Formula

C29-H41-F2-N5-O

Molecular Weight

513

Therapeutic Category

Antiviral agent, treatment of HIV infection

Chemical Names

(S)-4,4-Difluorcyclohexancarbonsäure-{(1R,3s,5S)-3-[3-(3-isopropyl-5-methyl-[1,2,4]triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}amid (IUPAC)

4,4-Difluoro-N-[(1S)-3-{(1R,3s,5S)-3-[3-methyl-5-(propan-2-yl)4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-phenylpropyl]cyclohexanecarboxamide (WHO)

Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-

Foreign Names

• Maravirocum (Latin)
• Maraviroc (German)
• Maraviroc (French)
• Maraviroc (Spanish)

Generic Names

• UK-382055 (IS)
• UK-395859 (IS)
• UK-408030 (IS)
• UK-418526 (IS)
• UK-427857 (IS: Pfizer)

Brand Names

• Celsentri
  Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Germany; Pfizer, Denmark; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Italy; Pfizer, Netherlands; Pfizer, Norway; Pfizer Limited, Austria; ViiV, Switzerland



• CELSENTRI
  Pfizer, Sweden



• Celsetri
  Keri Pharma, Slovenia



• Selzentry
  ViiV Healthcare, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.